How does COVID-19 affect prostate cancer?

Published Date: 14 Mar 2023

As the COVID-19 pandemic spreads, access to and delivery of health services has been disrupted like never before. How has it affected the treatment of prostate cancer?

Read Full News

Latest News

S1 Episode 2: Recurrent UTIs in Older Women

Drs Anne Lenore Ackerman and Melissa Kaufman discuss recurrent UTIs in older women and its association with genitourinary syndrome of menopause.

Herpes Simplex Virus Esophagitis in an Immunocompetent Man

Severe esophageal symptoms that do not respond to standard treatment may warrant endoscopic evaluation and targeted diagnostic testing.

Tailoring Prostate Cancer Care in Men With Limited Longevity

Not every man with prostate cancer benefits from aggressive therapy. Drs Timothy Daskivich and John Leppert explore how to avoid overtreatment in men with limited longevity.

Older Man With Lyme Neuroborreliosis After Tick Bite

Facial palsy, encephalitis, and cerebrospinal fluid abnormalities ultimately indicated Lyme neuroborreliosis, despite early doxycycline treatment.

HLTH Europe 2026

Read clinically focused news coverage of key developments from HLTH Europe 2026

Data Updates Shift Treatment Standards in Gyn-Oncology

At ASCO 2026, Dr Susana Campos reviews pivotal gyn-onc updates, from practice-changing long-term IO survival in endometrial cancer to next-generation ADCs.

Todays Updates

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

Drug holidays are proving possible in hormone-sensitive metastatic prostate cancer — and some men stay off treatment for years.

CAR T Cells Produce 10-Year Remissions in Some With Lymphoma

Researchers evaluated long-term outcomes in patients with relapsed or refractory B-cell non-Hodgkin lymphomas receiving CAR T-cell therapy.

Todays Updates

Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?

Drug holidays are proving possible in hormone-sensitive metastatic prostate cancer — and some men stay off treatment for years.

CAR T Cells Produce 10-Year Remissions in Some With Lymphoma

Researchers evaluated long-term outcomes in patients with relapsed or refractory B-cell non-Hodgkin lymphomas receiving CAR T-cell therapy.

Latest News

Drs Anne Lenore Ackerman and Melissa Kaufman discuss recurrent UTIs in older women and its association with genitourinary syndrome of menopause.

Severe esophageal symptoms that do not respond to standard treatment may warrant endoscopic evaluation and targeted diagnostic testing.

Not every man with prostate cancer benefits from aggressive therapy. Drs Timothy Daskivich and John Leppert explore how to avoid overtreatment in men with limited longevity.

Facial palsy, encephalitis, and cerebrospinal fluid abnormalities ultimately indicated Lyme neuroborreliosis, despite early doxycycline treatment.

Read clinically focused news coverage of key developments from HLTH Europe 2026

At ASCO 2026, Dr Susana Campos reviews pivotal gyn-onc updates, from practice-changing long-term IO survival in endometrial cancer to next-generation ADCs.

News All Time

S4 Episode 4: How Confident Should We Be in Psoriasis Biosimilars?

Join Drs Steven Feldman and Jonathan Kay as they examine the data on safety, switching, and confidence in psoriasis biosimilars.

10 Medical Breakthroughs Transforming Clinical Care

CRISPR cures for sickle cell disease, gene therapy for hemophilia A, and expanding CAR T cell uses point to a new era of potentially curative, personalized treatments.

Imaging and Staging Essentials in Uveal Melanoma

Dr Teresa Amaral reviews new uveal melanoma guidelines, focusing on AJCC 8th Edition staging, the Liverpool prognostic tool, and the essential role of BAP1 and PRAME expression.

Vaccinated Woman With COVID Rebound After Ensitrelvir

A possible first case of COVID recurrence after ensitrelvir: a vaccinated woman whose antigen levels fall and then rebound, with symptoms returning 1 day after treatment.

Optimizing UC Therapy in the Presence of Comorbidities

Dr Corey Siegel discusses the importance of individualized therapy selection for ulcerative colitis in the presence of comorbidities.

A New Ultrapotent Opioid Emerges: What Is Cychlorphine?

Dr Robert Glatter speaks with toxicologist Dr Lewis Nelson about cychlorphine, a newly emerging synthetic opioid linked to fatal overdoses, and what clinicians should understand about detection, naloxone response, and the evolving drug landscape.

ESMO Update: New Guidance for Rare Uveal Melanoma

Dr Teresa Amaral breaks down the essential new guidelines for uveal melanoma. Stay ahead of the latest standards in patient care.

Soccer ‘Headers’ Acutely Raise Brain Damage Biomarkers

Study findings are concerning, but will the world’s most popular sport ban the practice of heading the ball?

Lipid Guidelines: Four Major Concerns

Too many Class I recommendations lacking supporting data from randomized trials and intellectual conflicts of interest are among John Mandrola’s complaints about the ACC/AHA guidelines on dyslipidemia.

Canadian EHR Interoperability Weak, Uneven, Harming Patients

Most Canadian physicians use electronic health records, but a lack of connectivity means that patient health information remains siloed across different software programs.

Angiolipoleiomyoma Masquerading as Leiomyoma in a Woman

A 45-year-old woman with a 2-year vaginal foreign body sensation and constipation has a large posterior vaginal wall mass; a biopsy suggests leiomyoma, but excision reveals angiolipoleiomyoma.

Beyond CAR-T: The Rising Potential of Natural Killer Cells

Prof David Kerr explores gene-edited NK cells and allogeneic banks as a potent, ‘off-the-shelf’ alternative to autologous CAR-T infusions.

Adding Lanes to the Healthcare Highway

Patients can now call, message, upload photos, complete e-visits, see primary care, go to urgent care, or request specialty care directly. And yet the backlog keeps growing. So does the inbox.

‘Too Good to Be True?’ GLP-1s and Breast Cancer Survival

Dr F. Perry Wilson breaks down study findings suggesting a link between GLP-1 drugs and improved outcomes among patients with breast cancer and obesity.

Upper GI Disorders: New Evidence May Refine Practice

Dr David Johnson summarizes pivotal DDW 2026 studies, spotlighting emerging evidence across upper GI disorders — from Barrett’s esophagus surveillance to pancreatitis management.

Testosterone Is Back; Have We Learned From Our Mistakes?

A new push to prescribe testosterone replacement therapy led this cardiologist to review the cardiovascular risk data.

Recommended News For You

Approved BTK Inhibitor Without Covalent Bond for CLL.

Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars

For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.

Gene Therapy for Rare Brain Disease Effective, but Comes With Blood Cancer Risk

Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL

Cancer After Weight Loss; How Older Adults Use the Healthcare System.

Getting ahead of head and neck cancer

Recommended Articles For You

Understanding the HAS-BLED Score: What It Is and Why It Matters  

Ear Emergency: Understanding the Causes and Treatment for Auricular Hematoma 

Emerging Trends in Oncology for Modern Medicine 

The Future of Oncology: Innovations Every Doctor Should Know 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Reasons Behind Refusing Stem Cell Transplantation in Certain Myeloma Patients.

2.

CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy Record

3.

Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer

4.

Efanesoctocog Alfa Prevented Bleeding in Kids With Severe Hemophilia A

5.

What are the factors that cause oral mucositis to be severe after receiving radiation for head and neck cancer?

1.

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer

2.

Circulating Tumor Cells & Platelet Interactions: Crosstalk for Therapeutic Advances

3.

Decoding the Padua Score to Prevent Blood Clots in High-Risk Patients

4.

Exploring The Science Of Hematopoietic Stem Cell Transplantation: What You Need To Know

5.

Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

2.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

4.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot